ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.766,57
-1,09%
S&P 500
6.040,04
1,10%
US Dollar vs BRL
6,73685
0,04%
Bitcoin
95.731,58
-3,60%
Brent Oil
73,475
0,26%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Iovance Biotherapeutics Inc (IOVA)

  7. Iovance Biotherapeutics Inc (IOVA) Notícias

IOVA

Iovance Biotherapeutics (IOVA)

Iovance Biotherapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IOVA
DataHoraFonteTítuloCódigoCompanhia
20/12/202419:00GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
18/12/202419:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
13/12/202419:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IOVAIovance Biotherapeutics Inc
02/12/202419:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
26/11/202418:01GlobeNewswire Inc.Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory OfficerNASDAQ:IOVAIovance Biotherapeutics Inc
21/11/202419:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
07/11/202419:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IOVAIovance Biotherapeutics Inc
07/11/202418:01GlobeNewswire Inc.Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024NASDAQ:IOVAIovance Biotherapeutics Inc
31/10/202417:01GlobeNewswire Inc.Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
03/09/202418:00GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming ConferencesNASDAQ:IOVAIovance Biotherapeutics Inc
08/08/202417:01GlobeNewswire Inc.Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024NASDAQ:IOVAIovance Biotherapeutics Inc
29/07/202417:01GlobeNewswire Inc.Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
28/06/202408:00GlobeNewswire Inc.Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced MelanomaNASDAQ:IOVAIovance Biotherapeutics Inc
24/05/202417:01GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming Conferences and EventsNASDAQ:IOVAIovance Biotherapeutics Inc
23/05/202418:00GlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
17/05/202418:15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:IOVAIovance Biotherapeutics Inc
09/05/202417:01GlobeNewswire Inc.Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:IOVAIovance Biotherapeutics Inc
01/05/202407:01GlobeNewswire Inc.Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
24/04/202417:01GlobeNewswire Inc.Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
04/03/202408:30GlobeNewswire Inc.Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
28/02/202418:01GlobeNewswire Inc.Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates NASDAQ:IOVAIovance Biotherapeutics Inc
22/02/202410:45GlobeNewswire Inc.Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
21/02/202418:44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IOVAIovance Biotherapeutics Inc
20/02/202408:30GlobeNewswire Inc.Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common StockNASDAQ:IOVAIovance Biotherapeutics Inc
16/02/202417:38GlobeNewswire Inc.Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
16/02/202417:19GlobeNewswire Inc.Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced MelanomaNASDAQ:IOVAIovance Biotherapeutics Inc
14/02/202408:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IOVAIovance Biotherapeutics Inc
28/12/202309:27IH Market NewsWall Street Highlights: Amazon to Introduce Ads on Prime Video, JD.com Raises Salaries in 2024, and MoreNASDAQ:IOVAIovance Biotherapeutics Inc
27/12/202309:54Dow Jones NewsIovance Shares Fall Premarket As FDA Places Study On Hold After Patient DeathNASDAQ:IOVAIovance Biotherapeutics Inc
27/12/202309:00GlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:IOVA

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados